Board Archives - Page 19 of 34

02 Dec Information mensuelle le contrat de liquidité et sur le nombre total de droits de vote

Posted at 15:46h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 2 decembre 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions...

02 Dec Liquidity Agreement Monthly Update and Total Voting Rights

Posted at 15:43h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 2 December 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to...

06 Nov Nouvel emprunt à terme et résiliation de l’emprunt obligataire convertible

Posted at 07:00h in Board, Novacyt Group, Products

Paris, France et Camberley, UK – 6 novembre 2019 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce aujourd'hui avoir convenu d’un prêt à...

06 Nov New term loan and termination of convertible bond facility

Posted at 07:00h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 6 November 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has agreed a €5.0m four-year term loan....

01 Nov Information mensuelle le contrat de liquidité et sur le nombre total de droits de vote

Posted at 19:43h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 1 novembre 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat...

01 Nov Liquidity Agreement Monthly Update and Total Voting Rights

Posted at 07:41h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 1 November 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to...

07 Oct INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

Posted at 10:43h in Board, Novacyt Group, Products

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers https://novacyt.com/wp-content/uploads/2019/10/NOVACYT_CP_Droits-de-vote_2019-Oct-2019.pdf ...

07 Oct Lancement d’un nouveau test de diagnostic respiratoire moléculaire pour le marché américain

Posted at 07:09h in Board, Novacyt Group, Products

Le test multiplex permet d’identifier jusqu'à 37 agents respiratoires pathogènes Paris, France et Camberley, Royaume-Uni – 7 octobre 2019 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic...

07 Oct New molecular respiratory panel ready for the US market

Posted at 07:07h in Board, Novacyt Group, Products

Multiplex test identifies up to 37 respiratory pathogens Paris, France and Camberley, UK – 7 October 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces...

03 Oct Conversion of Loan Notes

Posted at 17:00h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 3 October 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with...

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others